The DDW Summer 2026 issue examines the multi-compound approach to autism, the outlook for GLP-1 therapies and highlights drug discovery innovators and investors – investment challenges and opportunities for drug developers.

Other features in the Summer issue include:

• The importance of tech and collaboration for immunotherapies
• The challenges of cancer drug resistance
• Where the value of AI lies in drug discovery